{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T14:24:44Z","timestamp":1773757484589,"version":"3.50.1"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Dermatofibrosarcoma protuberans (DFSP) is a rare low-grade tumor that typically does not metastasize but often recurs. Fibrosarcomatous DFSP (FS-DFSP) is associated with a substantially higher rate of metastasis and a poorer prognosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>This study sought to investigate the epidemiological, histopathological, and clinical characteristics of DFSP, especially with a particular focus on FS-DFSP.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MATERIALS AND METHODS<\/jats:title>\n            <jats:p>Clinical data from 254 patients treated between January 1999 and July 2018 were retrospectively reviewed. Endpoints of the study were the incidence of significant disease-related clinical events.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>Follow-up data from 211 patients were available for analysis, with a median follow-up time of 38 months (range: 1\u2013196 months). The 5-year recurrence-free survival rate of patients underwent wide-local excision (WLE) was 97.1%. Patients underwent WLE exhibited a significantly decreased recurrence rate relative to patients treated through local excision (2.9% vs 37.7%; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; .001). Fibrosarcomatous DFSP had significantly higher rates of distant metastasis (66.7% [<jats:italic toggle=\"yes\">n<\/jats:italic> = 4] vs 2.0% [<jats:italic toggle=\"yes\">n<\/jats:italic> = 4]; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; .001) and long-term mortality (50.0% [<jats:italic toggle=\"yes\">n<\/jats:italic> = 3] vs 1.5% [<jats:italic toggle=\"yes\">n<\/jats:italic> = 3]; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; .001), compared with classical DFSP (C-DFSP).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>Wide-local excision is an effective means of reducing DFSP recurrence. Rates of metastasis are higher for FS-DFSP than for C-DFSP, with the former having significantly poorer outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000002578","type":"journal-article","created":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T01:44:05Z","timestamp":1596851045000},"page":"e26-e30","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Dermatofibrosarcoma Protuberans: A Clinicopathologic and Therapeutic Analysis of 254 Cases at a Single Institution"],"prefix":"10.1097","volume":"47","author":[{"given":"Changyou","family":"Jing","sequence":"first","affiliation":[{"name":"Orthopedics, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongtu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Pathology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Orthopedics, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengji","family":"Yu","sequence":"additional","affiliation":[{"name":"Orthopedics, and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,8,5]]},"reference":[{"key":"R1-20250731","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/SCS.0000000000003203","article-title":"Incidence and outcomes of dermatofibrosarcoma protuberans in the US pediatric population","volume":"28","author":"Rubio","year":"2017","journal-title":"J Craniofac Surg"},{"issue":"Suppl 1","key":"R2-20250731","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1097\/DSS.0000000000000300","article-title":"Incidence and survival of primary dermatofibrosarcoma protuberans in the United States","volume":"42","author":"Kreicher","year":"2016","journal-title":"Dermatol Surg"},{"key":"R3-20250731","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2310\/7750.2014.13192","article-title":"A clinicopathologic review of a case series of dermatofibrosarcoma protuberans with fibrosarcomatous differentiation","volume":"19","author":"Kuzel","year":"2015","journal-title":"J Cutan Med Surg"},{"key":"R4-20250731","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.anndiagpath.2016.09.013","article-title":"Dermatofibrosarcoma protuberans: pathology, genetics, and potential therapeutic strategies","volume":"25","author":"Thway","year":"2016","journal-title":"Ann Diagn Pathol"},{"key":"R5-20250731","first-page":"375","article-title":"Dermatofibrosarcoma protuberans: from translocation to targeted therapy","volume":"12","author":"Noujaim","year":"2015","journal-title":"Cancer Biol Med"},{"key":"R6-20250731","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/cncr.20678","article-title":"Dermatofibrosarcoma protuberans","volume":"101","author":"Mendenhall","year":"2004","journal-title":"Cancer"},{"key":"R7-20250731","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/PGP.0000000000000472","article-title":"PDGFB rearrangements in dermatofibrosarcoma protuberans of the vulva: a study of 11 cases including myxoid and fibrosarcomatous variants","volume":"37","author":"Jahanseir","year":"2018","journal-title":"Int J Gynecol Pathol"},{"key":"R8-20250731","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1038\/s41379-018-0089-4","article-title":"Alternative PDGFD rearrangements in dermatofibrosarcomas protuberans without PDGFB fusions","volume":"31","author":"Dadone-Montaudie","year":"2018","journal-title":"Mod Pathol"},{"key":"R9-20250731","doi-asserted-by":"crossref","first-page":"642549","DOI":"10.1155\/2015\/642549","article-title":"Wide local excision for dermatofibrosarcoma protuberans: a single-center series of 90 patients","volume":"2015","author":"Kim","year":"2015","journal-title":"Biomed Res Int"},{"key":"R10-20250731","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/jso.22000","article-title":"Dermatofibrosarcoma protuberans: clinical diagnoses and treatment results of 260 cases in China","volume":"105","author":"Cai","year":"2012","journal-title":"J Surg Oncol"},{"key":"R11-20250731","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1111\/jdv.14378","article-title":"Wide local excision vs. Mohs Tubingen technique in the treatment of dermatofibrosarcoma protuberans: a two-centre retrospective study and literature review","volume":"31","author":"Veronese","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R12-20250731","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/DSS.0000000000000910","article-title":"A comparison of Mohs micrographic surgery and wide local excision for treatment of dermatofibrosarcoma protuberans with long-term follow-up: the mayo clinic experience","volume":"43","author":"Lowe","year":"2017","journal-title":"Dermatol Surg"},{"key":"R13-20250731","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11864-019-0628-3","article-title":"Current update on the molecular biology of cutaneous sarcoma: dermatofibrosarcoma protuberans","volume":"20","author":"Iwasaki","year":"2019","journal-title":"Curr Treat Options Oncol"},{"key":"R14-20250731","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1586\/14737140.2015.1052799","article-title":"Current treatment options for dermatofibrosarcoma protuberans","volume":"15","author":"Rutkowski","year":"2015","journal-title":"Expert Rev Anticancer Ther"},{"key":"R15-20250731","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13014-019-1226-z","article-title":"Role of postoperative radiotherapy in dermatofibrosarcoma protuberans: a propensity score-matched analysis","volume":"14","author":"Du","year":"2019","journal-title":"Radiat Oncol"},{"key":"R16-20250731","first-page":"268","article-title":"Evaluation of the role of radiotherapy in the management of dermatofibrosarcoma protuberans","volume":"18","author":"Uysal","year":"2013","journal-title":"J BUON"},{"key":"R17-20250731","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/2229-5178.110591","article-title":"Outcome of wide local excision in dermatofibrosarcoma protuberans and use of radiotherapy for margin-positive disease","volume":"4","author":"Hamid","year":"2013","journal-title":"Indian Dermatol Online J"},{"key":"R18-20250731","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1158\/1078-0432.CCR-15-1243","article-title":"Efficacy and biological activity of imatinib in metastatic dermatofibrosarcoma protuberans (DFSP)","volume":"22","author":"Stacchiotti","year":"2016","journal-title":"Clin Cancer Res"},{"key":"R19-20250731","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1158\/1078-0432.CCR-13-1411","article-title":"Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase II DeCOG trial with long-term follow-up","volume":"20","author":"Ugurel","year":"2014","journal-title":"Clin Cancer Res"},{"key":"R20-20250731","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1002\/1097-0142(20000615)88:12<2711::AID-CNCR9>3.0.CO;2-M","article-title":"Dermatofibrosarcoma protuberans: a clinicopathologic analysis of patients treated and followed at a single institution","volume":"88","author":"Bowne","year":"2000","journal-title":"Cancer"},{"key":"R21-20250731","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jaad.2006.09.006","article-title":"Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002","volume":"56","author":"Criscione","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R22-20250731","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1053\/j.semdp.2012.01.002","article-title":"Dermatofibrosarcoma protuberans: a comprehensive review and update on diagnosis and management","volume":"30","author":"Llombart","year":"2013","journal-title":"Semin Diagn Pathol"},{"key":"R23-20250731","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/2000656X.2013.812969","article-title":"Dermatofibrosarcoma protuberans: clinical series, national Danish incidence data and suggested guidelines","volume":"48","author":"Akram","year":"2014","journal-title":"J Plast Surg Hand Surg"},{"key":"R24-20250731","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ctrv.2008.06.002","article-title":"Dermatofibrosarcoma protuberans: wide local excision vs. Mohs micrographic surgery","volume":"34","author":"Paradisi","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"R25-20250731","first-page":"1060","article-title":"Mohs micrographic surgery for dermatofibrosarcoma protuberans: university of Miami and NYU experience","volume":"28","author":"Nouri","year":"2002","journal-title":"Dermatol Surg"},{"key":"R26-20250731","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11864-017-0498-5","article-title":"Dermatofibrosarcoma protuberans","volume":"18","author":"Acosta","year":"2017","journal-title":"Curr Treat Options Oncol"},{"key":"R27-20250731","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1016\/j.ejca.2015.06.108","article-title":"Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline","volume":"51","author":"Saiag","year":"2015","journal-title":"Eur J Cancer"},{"key":"R28-20250731","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.bjps.2014.05.031","article-title":"Dermatofibrosarcoma protuberans in children and adolescents: clinical presentation, histology, treatment, and review of the literature","volume":"67","author":"Tsai","year":"2014","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R29-20250731","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/jdv.13601","article-title":"The efficacy of adjuvant radiotherapy in dermatofibrosarcoma protuberans: a systemic review and meta-analysis","volume":"30","author":"Chen","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R30-20250731","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ijrobp.2013.02.024","article-title":"Dermatofibrosarcoma protuberans: long-term outcomes of 53 patients treated with conservative surgery and radiation therapy","volume":"86","author":"Castle","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R31-20250731","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/cncr.28657","article-title":"Sarcoma classification: an update based on the 2013 world health organization classification of tumors of soft tissue and bone","volume":"120","author":"Doyle","year":"2014","journal-title":"Cancer"},{"key":"R32-20250731","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jaad.2014.11.020","article-title":"Prognostic impact of fibrosarcomatous transformation in dermatofibrosarcoma protuberans: a cohort study","volume":"72","author":"Hoesly","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"R33-20250731","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00000478-200604000-00002","article-title":"The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans","volume":"30","author":"Abbott","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R34-20250731","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00000478-199805000-00009","article-title":"Fibrosarcomatous (\u201chigh-grade\u201d) dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance","volume":"22","author":"Mentzel","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"R35-20250731","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jaad.2014.03.018","article-title":"A systematic review of outcome data for dermatofibrosarcoma protuberans with and without fibrosarcomatous change","volume":"71","author":"Liang","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"R36-20250731","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/cncr.31924","article-title":"Outcome after surgical treatment of dermatofibrosarcoma protuberans: is clinical follow-up always indicated?","volume":"125","author":"Huis In 't Veld","year":"2019","journal-title":"Cancer"},{"key":"R37-20250731","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/jamadermatol.2018.4940","article-title":"Imatinib treatment for locally advanced or metastatic dermatofibrosarcoma protuberans: a systematic review","volume":"155","author":"Navarrete-Dechent","year":"2019","journal-title":"JAMA Dermatol"},{"key":"R38-20250731","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ejso.2017.03.011","article-title":"Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate - the impact of fibrosarcomatous transformation","volume":"43","author":"Rutkowski","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"R39-20250731","doi-asserted-by":"crossref","first-page":"e773","DOI":"10.1097\/MD.0000000000000773","article-title":"Target therapy of unresectable or metastatic dermatofibrosarcoma protuberans with imatinib mesylate: an analysis on 22 Chinese patients","volume":"94","author":"Wang","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"R40-20250731","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/ijc.25826","article-title":"Dermatofibrosarcoma protuberans-derived fibrosarcoma: clinical history, biological profile and sensitivity to imatinib","volume":"129","author":"Stacchiotti","year":"2011","journal-title":"Int J Cancer"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002578","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T22:15:35Z","timestamp":1754000135000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,5]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000002578","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,5]]}}}